Elizabeth Lerner Papautsky receives $250,000 research grant from the National Comprehensive Cancer Network and Pfizer Global Medical Grants
Introduction
Elizabeth Lerner Papautsky is the principal investigator of "Developing a human-centered information toolkit to increase trastuzumab biosimilar uptake" funded by a one-year, $250,000 research grant from the National Comprehensive Cancer Network and Pfizer Global Medical Grants. Collaborators include Maryam Lustberg (OSU), Deanna Attai (UCLA), Martha Carlson (patient collaborator) and Sheila McGlown (patient collaborator).